Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging

被引:39
作者
Dodgshun, Andrew J. [1 ]
Maixner, Wirginia J. [2 ]
Hansford, Jordan R. [1 ]
Sullivan, Michael J. [1 ,3 ]
机构
[1] Royal Childrens Hosp, Childrens Canc Ctr, Melbourne, Vic, Australia
[2] Royal Childrens Hosp, Dept Neurosurg, Melbourne, Vic, Australia
[3] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
关键词
pilocytic astrocytoma; gross-total resection; surveillance; oncology; PHOSPHATURIC MESENCHYMAL TUMOR; FGF23; MESSENGER-RNA; ONCOGENIC OSTEOMALACIA; VARIANT; DIAGNOSIS; BONE;
D O I
10.3171/2015.9.PEDS15449
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Pilocytic astrocytomas (PAs) are common brain tumors in children. Optimal management of PA is gross total resection (GTR), after which event-free survival (EFS) is excellent. The tempo of recurrences, when they do occur, is relatively sparsely reported, and there is no agreed upon surveillance recommendation for patients in this category. It has been suggested that surveillance MRI is performed too frequently and could be safely reduced in both frequency and duration. The authors conducted a retrospective review of pediatric patients with PA who underwent GTR at a single institution over an 18-year period and who had documented recurrences. METHODS All patients under 18 years of age who had undergone GTR of a PA between 1996 and 2013 were included in the study. Clinical, radiological, and tumor characteristics were recorded. RESULTS Sixty-seven patients met the criteria for GTR over the period studied. The 5-year EFS rate was 95% (95% CI 89%-100%) and overall survival was 100%. Recurrences showed a nonsignificant trend of occurring more commonly in patients with persistent nonenhancing FLAIR abnormalities after surgery, but there was no difference with regard to tumor location. All recurrences occurred before 3 years postresection, all were asymptomatic, and all patients were observed for at least one additional scan after the initial detection during routine surveillance MRI before further therapy was undertaken. CONCLUSIONS EFS and overall survival are excellent after GTR in this population with PAs. Progression after recurrence occurs slowly and is asymptomatic. A less intensive schedule of MRI surveillance in this group of patients would result in time and cost savings, without compromising safety. The authors suggest a schedule of 6 MRI scans to be obtained postoperatively, at 3-6 months, then at 1, 2, 3.5, and 5 years.
引用
收藏
页码:569 / 577
页数:9
相关论文
共 32 条
[1]   Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors [J].
Andreopoulou, Panagiota ;
Dumitrescu, Claudia E. ;
Kelly, Marilyn H. ;
Brillante, Beth A. ;
Peck, Carolee M. Cutler ;
Wodajo, Felasfa M. ;
Chang, Richard ;
Collins, Michael T. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (06) :1295-1302
[2]   RT-PCR Analysis for FGF23 Using Paraffin Sections in the Diagnosis of Phosphaturic Mesenchymal Tumors With and Without Known Tumor Induced Osteomalacia [J].
Bahrami, Armita ;
Weiss, Sharon W. ;
Montgomery, Elizabeth ;
Horvai, Andrew E. ;
Jin, Long ;
Inwards, Carrie Y. ;
Folpe, Andrew L. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (09) :1348-1354
[3]  
Bower Regina S, 2012, Surg Neurol Int, V3, P151, DOI 10.4103/2152-7806.104745
[4]   Oncogenic osteomalacia - A complex dance of factors [J].
Carpenter, TO .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1705-1708
[5]   A Novel Chromogenic In Situ Hybridization Assay for FGF23 mRNA in Phosphaturic Mesenchymal Tumors [J].
Carter, Jodi M. ;
Caron, Bolette L. ;
Dogan, Ahmet ;
Folpe, Andrew L. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (01) :75-83
[6]   Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor - Case report [J].
David, K ;
Revesz, T ;
Path, MRC ;
Kratimenos, G ;
Krausz, T ;
Path, FRC ;
Crockard, HA .
JOURNAL OF NEUROSURGERY, 1996, 84 (02) :288-292
[7]   Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients - Proposal of diagnostic criteria using FGF23 measurement [J].
Endo, Itsuro ;
Fukumoto, Seiji ;
Ozono, Keiichi ;
Namba, Noriyuki ;
Tanaka, Hiroyuki ;
Inoue, Daisuke ;
Minagawa, Masanori ;
Sugimoto, Toshitsugu ;
Yamauchi, Mika ;
Michigami, Toshimi ;
Matsumoto, Toshio .
BONE, 2008, 42 (06) :1235-1239
[8]  
EVANS DJ, 1972, LANCET, V1, P353
[9]   Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity - An analysis of 32 cases and a comprehensive review of the literature [J].
Folpe, AL ;
Fanburg-Smith, JC ;
Billings, SD ;
Bisceglia, M ;
Bertoni, F ;
Cho, JY ;
Econs, MJ ;
Inwards, CY ;
de Beur, SMJ ;
Mentzel, T ;
Montgomery, E ;
Michal, M ;
Miettinen, M ;
Mills, SE ;
Reith, JD ;
O'Connell, JX ;
Rosenberg, AE ;
Rubin, BP ;
Sweet, DE ;
Vinh, TN ;
Wold, LE ;
Wehrli, BM ;
White, FKE ;
Zaino, RJ ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (01) :1-30
[10]   Oncogenic osteomalacia: case report and review of head and neck associated tumours [J].
Gonzalez-Compta, X ;
Manos-Pujol, M ;
Foglia-Fernandez, M ;
Peral, E ;
Condom, E ;
Claveguera, T ;
Dicenta-Sousa, M .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1998, 112 (04) :389-392